Quarterly Transactions Made in Sangamo Therapeutics, Inc (SGMO)
This table provides information about the institutional ownership of Sangamo Therapeutics, Inc (SGMO). The information is specifically focused on institutions that hold shares of SANGAMO THERAPEUTICS, INC.
Shares Purchased
Shares Sold
Quarter | Buy | Sell | Net Activity | |||||
---|---|---|---|---|---|---|---|---|
New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
Q4 2021 | 6,454,471 | 1,133,075 | 7,587,546 | 3,696,944 | 1,250,612 | 4,947,556 | 2,639,990 | |
Q1 2022 | 7,170,226 | 1,156,478 | 8,326,704 | 5,254,662 | 910,513 | 6,165,175 | 2,161,529 | |
Q2 2022 | 13,396,538 | 2,443,020 | 15,839,558 | 1,857,128 | 1,119,477 | 2,976,605 | 12,862,953 | |
Q3 2022 | 9,772,941 | 4,106,186 | 13,879,127 | 3,837,087 | 22,496 | 3,859,583 | 10,019,544 | |
Q4 2022 | 11,714,958 | 908,101 | 12,623,059 | 4,483,343 | 19,575 | 4,502,918 | 8,120,141 | |
Q1 2023 | 14,056,633 | 1,703,144 | 15,759,777 | 6,130,696 | 33,000 | 6,163,696 | 9,596,081 | |
Q2 2023 | 12,672,621 | 2,770,877 | 15,443,498 | 15,704,445 | 0 | 15,704,445 | -260,947 | |
Q3 2023 | 5,321,243 | 658,742 | 5,979,985 | 5,735,271 | 0 | 5,735,271 | 244,714 | |
Q4 2023 | 13,082,159 | 995,672 | 14,077,831 | 14,276,144 | 905 | 14,277,049 | -199,218 | |
Q1 2024 | 10,477,266 | 18,550,461 | 29,027,727 | 12,720,948 | 1,431 | 12,722,379 | 16,305,348 | |
Q2 2024 | 9,663,994 | 2,288,535 | 11,952,529 | 23,100,196 | 0 | 23,100,196 | -11,147,667 | |
Q3 2024 | 3,981,721 | 523,000 | 4,504,721 | 9,574,043 | 26,383 | 9,600,426 | -5,095,705 | |
Q4 2024 | 322,320 | 106,615 | 428,935 | 153,580 | 0 | 153,580 | 275,355 |